Chardan Capital reiterated coverage on Homology Medicines with a new price target

2/22/22 8:49:17 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Chardan Capital reiterated coverage of Homology Medicines with a rating of Buy and set a new price target of $15.00 from $25.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$FIXX

Date	Price Target	Rating	Analyst
7/28/2023	$9.00 → $1.50	Outperform → Neutral	Robert W. Baird
2/28/2022	$30.00 → $20.00	Buy	HC Wainwright & Co.
2/22/2022	$25.00 → $9.00	Buy	B of A Securities
2/22/2022	$35.00 → $29.00	Neutral	BTIG Research
2/22/2022		Outperform → Sector Perform	RBC Capital Mkts
2/22/2022	$25.00 → $15.00	Buy	Chardan Capital
2/22/2022	$35.00 → $29.00	Buy	BTIG
2/22/2022	$30.00 → $4.00	Outperform → Sector Perform	RBC Capital